Linde India has announced the acquisition of 100% of the share capital of Airtech Cryogenic Gases Private Limited (“Airtech”). This strategic move, approved by the Board of Directors, aims to strengthen Linde India’s core business, scale of operations, and overall growth. The Share Purchase Agreement has been executed, and upon fulfillment of conditions, Airtech will become a wholly-owned subsidiary. The acquisition cost is estimated at ₹111.20 Crore.
Linde India Acquires Airtech Cryogenic Gases
Linde India has announced a significant strategic acquisition, entering into an agreement to purchase 100% of the share capital of Airtech Cryogenic Gases Private Limited (“Airtech”). This decision was formally approved by the Board of Directors on Friday, 13 November 2026. The acquisition is expected to bolster Linde India’s core business operations, enhance its market scale, and drive future growth.
Deal Details and Rationale
The Share Purchase Agreement (“SPA”) with the shareholders of Airtech has been executed on the same day as the board approval. Following the fulfillment of all conditions precedent and the successful completion of the transaction, Airtech Cryogenic Gases Private Limited will officially become a wholly-owned subsidiary of Linde India. The company stated that this acquisition is designed to strengthen Linde India’s core business, scale, and growth.
Financials and Timeline
The estimated cost of acquisition is ₹111.20 Crore, subject to closing adjustments. The transaction is anticipated to be completed within an indicative timeframe of 8 weeks. Airtech Cryogenic Gases Private Limited is engaged in the manufacturing, sales, and distribution of industrial and medical cryogenic gases, operating an Air Separation Unit in Dholka, Gujarat. For the nine months of operation ending in March 2026, Airtech reported a turnover of ₹2,899.95 lakhs.
Source: BSE
